SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?

To: F. Lynn who wrote (3800)3/19/1998 1:10:00 AM
From: Andrew Q. Viet  Read Replies (1) | Respond to of 7054
 
The patent wasn't the TAD itself, but the electronic transaction of the TAD. It's the process of the transaction that is patented. Whenever you get a patent for a something it's enforcible. Look AZT was synthesized by NIH ( National Institute of Health). But Glaxo-wellcome found the application of that drug and they got the patent. It's basically similar the electronic transation of the TAD. AZT was known before Glaxo-Wellcome got the patent.



To: F. Lynn who wrote (3800)3/19/1998 1:15:00 AM
From: Goulds  Read Replies (1) | Respond to of 7054
 
Wrong, Flynn. The patent office does not accept the patent application until a rather intensive search is done to make sure there are no existing patents for that item. The patent office does do exhaustive checks. And you are right when you say the real battle begins in court. I, too, have been saying that all along.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News